Next Article in Journal
Discounting Health Gain: A Different View
Previous Article in Journal
Observational Study on the Therapeutic Management and Economic Burden of Adult Patients with Moderate to Severe Plaque Psoriasis in France—The POP Study
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Women and Children’s Real-World Economic and Drug Indicators from 2015 to 2019

1
National Drug Clinical Trial Institution and Pharmacy, Hainan Women and Children’s, Medical Center (Children’s Hospital of Fudan University at Hainan), Changbin Road, Xiuying District, Haikou 570100, China
2
Pediatric Medical Centre, Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan, China
3
School of Management, Hainan Medical University, Haikou, China
*
Author to whom correspondence should be addressed.
These authors have contributed equally to this work and share co-first authors.
These authors have contributed equally to this work and share co-corresponding authors.
J. Mark. Access Health Policy 2023, 11(1), 2270297; https://doi.org/10.1080/20016689.2023.2270297
Submission received: 16 May 2023 / Revised: 6 October 2023 / Accepted: 9 October 2023 / Published: 26 October 2023

Abstract

ABSTRACT Objectives: To obtain real-world data on rational drug use, pharmacoeconomic regarding women’s and children’s health and the benefits of Hainan free trade port (HFTP) health policies, we retrospectively investigated drug indicators, prescribing trend, and economic data. Method: We retrospectively gathered the data from the database of the hospital information system and the quality indicators of pharmacy; we compared the monthly indicators from 2015 to 2019. Results: In 2017, the HFTP maternal mortality ratio (MMR) was 24.46. In 2019, the HFTP infant mortality rate (‰) was 4.15, and the under-five mortality rate (‰) was 6.19. A total of 1,922,798 prescriptions included in the analysis, the defined daily dose of 2015–2019 ranged from 46.59 to 32.34. In 2019, the proportions of antibiotics prescribed in outpatient, emergency, and inpatient care were 14.19%, 16.68%, and 46.26%, respectively. The injection prescription percentage ranged from 13.08% to 8.08%. The proportion of medicine income to total hospital income of 2015–2019 ranged from 26.66% to 25.31%. Conclusion: According to the analysis of women’s and children’s real-world drug data, economic investment and strict quality control of antimicrobial stewardship programs can lead to the rational use of drugs.
Keywords: real-world study; pharmacoepidemiology; pharmacoeconomic analysis; rational drug use; antimicrobial stewardship program; antibiotic percent real-world study; pharmacoepidemiology; pharmacoeconomic analysis; rational drug use; antimicrobial stewardship program; antibiotic percent

Share and Cite

MDPI and ACS Style

Zou, J.; Zhang, C.; Jia, G.; Lu, W. Women and Children’s Real-World Economic and Drug Indicators from 2015 to 2019. J. Mark. Access Health Policy 2023, 11, 2270297. https://doi.org/10.1080/20016689.2023.2270297

AMA Style

Zou J, Zhang C, Jia G, Lu W. Women and Children’s Real-World Economic and Drug Indicators from 2015 to 2019. Journal of Market Access & Health Policy. 2023; 11(1):2270297. https://doi.org/10.1080/20016689.2023.2270297

Chicago/Turabian Style

Zou, Jun, Che Zhang, Guohua Jia, and Wei Lu. 2023. "Women and Children’s Real-World Economic and Drug Indicators from 2015 to 2019" Journal of Market Access & Health Policy 11, no. 1: 2270297. https://doi.org/10.1080/20016689.2023.2270297

Article Metrics

Back to TopTop